切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2018, Vol. 06 ›› Issue (02) : 118 -121. doi: 10.3877/cma.j.issn.2095-5820.2018.02.011

所属专题: 经典病例 经典病例 文献

病例讨论

母细胞性浆细胞样树突细胞肿瘤一例诊疗分析
周剑峰1, 陈建春1, 常娟1, 王立荣1, 楚玉兰1, 郑娟娟1, 谢春如1, 钟云峰1, 王超1, 潘建华1, 陈辉树1,()   
  1. 1. 300042 天津金域医学检验所血液病诊断中心
  • 收稿日期:2018-03-05 出版日期:2018-05-28
  • 通信作者: 陈辉树
  • 基金资助:
    广州海珠区科技计划项目资助课题(2012-ZD-02)

Clinical analysis of a case of Blastic plasmacytoid dendritic cell neoplasm

Jianfeng Zhou1, Jianchun Chen1, Juan Chang1   

  • Received:2018-03-05 Published:2018-05-28
引用本文:

周剑峰, 陈建春, 常娟, 王立荣, 楚玉兰, 郑娟娟, 谢春如, 钟云峰, 王超, 潘建华, 陈辉树. 母细胞性浆细胞样树突细胞肿瘤一例诊疗分析[J]. 中华临床实验室管理电子杂志, 2018, 06(02): 118-121.

Jianfeng Zhou, Jianchun Chen, Juan Chang. Clinical analysis of a case of Blastic plasmacytoid dendritic cell neoplasm[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2018, 06(02): 118-121.

图1 患者骨髓涂片图(瑞-吉氏染色,×1000)
图2 患者的免疫分型流式细胞图
图3 患者骨髓活检(HE染色,×40)和免疫组化(×100)图
1
Chan JKC, Jaffe ES, Ralfiaer E. Blastic NK-cell lymphoma// Jaffe ES, Harris NL, Stein H, et al. World health organization classification of tumonrs: Tumours of haematopoietic and lymphoid tissues[M]. Lyon: IARC Press, 2001: 214-215.
2
Facehetti F, Jones DM, Petrella T. Blastic plasmacytoid dendritic cell neoplasm// Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of heamatopioetics and lymphoid tissues. 4th ed[M]. Lyon: IARC Press, 2008:145-147.
3
Swerdlow SH, Petrella T, Pileri SA. Blastic plasmacytoid dendritic cell neoplasm// Campo E, Harris NL, et al. WHO classification of tumours of heamatopioetics and lymphoid tissues. Revised 4th ed[M]. Lyon: IARC Press, 2017:174-177.
4
Adachi, M., Maeda, K., Takekawa, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma[J]. Am J Hematol,1994,47(4):278-282.
5
Jegalian AG, Buxbaum NP, Facchetti F, et al. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and Clinical implications[J]. Haematologica, 2010,95(11):1873-1879.
6
Cota C, Vale E, Viana L, et al. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm- morphologic and phenotypic variability in a series of 33 patients [J]. Am J Surg Pathol, 2010,34(1):75-87.
7
Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CD4(+) CD56(+) malignancies[J]. Blood, 2002,99(5):1556-1563.
8
Leroux D, Mugneret F, Callanan M, et al. CD4(+), CD56(+)DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique [J]. Blood, 2002,99(11):4154-4159.
9
Idrees A, Zhang X, Setoodeh R, et al. Clinical features and outcomes of 24 cases of blastic plasmacytoid dendritic cell neoplasm-single institutional experience [J]. Blood, 2015,126(23):3755.
10
Tsagarakis NJ, Kentrou NA, Papadimitriou KA, et al. Acute lymphoplasmacytoid dendritic cell(DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group[J]. Leuk Res, 2010,34(4):438-446.
11
Pagano L, Valentini CG, Pulsoni A, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study[J]. Haematologica, 2013,98(2):239-246.
12
Roos-Weil D, Dietrich S, Boumendil A, et al. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation [J]. Blood, 2013,121(3):440-446.
13
Aoki T, Suzuki R, Kuwatsuka Y, et al. Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm[J]. Blood, 2015,125(23):3559-3562.
No related articles found!
阅读次数
全文


摘要